Skip to content Skip to footer
Rani Therapeutics Holdings (NASDAQ: RANI) has unveiled a transformative partnership with Japan’s Chugai Pharmaceutical Co. valued at up to $1.085 billion, coupled with a $60.3 million private placement that strengthens its capital position through 2028. The Chugai Collaboration Under the agreement, Chugai will make…